Otsuka Holdings Co., Ltd. (OTSKF)

Market Cap	37.89B +54.8%
Revenue (ttm)	15.83B +5.1%
Net Income	2.37B +7.3%
EPS	4.48 +9.7%
Shares Out	n/a
PE Ratio	16.00
Forward PE	n/a
Dividend	0.89 (1.38%)
Ex-Dividend Date	Jun 29, 2026

Volume	n/a
Open	64.57
Previous Close	64.57
Day's Range	64.57 - 64.57
52-Week Range	44.40 - 72.22
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 28, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 37,758
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKF

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Financial numbers in JPY